Premium
Homegrown private equity firm CX Partners is harvesting a rich return from a four-year-old investment in an Indian drugmaker that could potentially become its showcase investment as it raises its second fund.CX Partners sold shares worth Rs 111 crore ($17 million) in Hyderabad-based Natco Pharma Ltd on Wednesday, generating more ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.